Literature DB >> 16828999

Compressed mini-tablets as a biphasic delivery system.

Carla M Lopes1, José Manuel Sousa Lobo, João F Pinto, Paulo Costa.   

Abstract

Compressed mini-tablets systems are presented as a biphasic delivery system designed for zero-order sustained drug release. The outer layer that fills the void spaces between the mini-tablets was formulated to release the drug in a very short time (fast release), while the mini-tablets provided a prolonged release. Different composition (HPMC or EC) and number (10 or 21) of mini-tablets were used to obtain different drug release rates. The in vitro performance of these systems showed the desired biphasic behaviour: the drug contained in the fast releasing phase (powder enrobing the mini-tablets) dissolved within the first 2 min, whereas the drug contained in the mini-tablets was released at different rates, depending up on formulation. Based on the release kinetic parameters calculated, it can be concluded that mini-tablets containing HPMC were particularly suitable approaching to zero-order (constant) release over 8h time periods.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16828999     DOI: 10.1016/j.ijpharm.2006.05.063

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  10 in total

1.  Two release rates from monolithic carboxymethyl starch tablets: formulation, characterization, and in vitro/in vivo evaluation.

Authors:  Tien Canh Le; Mircea Alexandru Mateescu
Journal:  Drug Deliv Transl Res       Date:  2017-08       Impact factor: 4.617

2.  Development of Extended-Release Mini-Tablets Containing Metoprolol Supported by Design of Experiments and Physiologically Based Biopharmaceutics Modeling.

Authors:  Michele Georges Issa; Natalia Vieira de Souza; Bruna Wenyi Chuang Jou; Marcelo Dutra Duque; Humberto Gomes Ferraz
Journal:  Pharmaceutics       Date:  2022-04-19       Impact factor: 6.525

3.  Design and in vitro evaluation of novel sustained-release double-layer tablets of lornoxicam: utility of cyclodextrin and xanthan gum combination.

Authors:  Yassin El-Said Hamza; Mona Hassan Aburahma
Journal:  AAPS PharmSciTech       Date:  2009-11-18       Impact factor: 3.246

4.  Compressed matrix core tablet as a quick/slow dual-component delivery system containing ibuprofen.

Authors:  Carla Martins Lopes; José M Sousa Lobo; João F Pinto; Paulo C Costa
Journal:  AAPS PharmSciTech       Date:  2007-09-21       Impact factor: 3.246

Review 5.  Oral drug delivery systems comprising altered geometric configurations for controlled drug delivery.

Authors:  Kovanya Moodley; Viness Pillay; Yahya E Choonara; Lisa C du Toit; Valence M K Ndesendo; Pradeep Kumar; Shivaan Cooppan; Priya Bawa
Journal:  Int J Mol Sci       Date:  2011-12-22       Impact factor: 5.923

6.  Design and evaluation of gastroretentive levofloxacin floating mini-tablets-in-capsule system for eradication of Helicobacter pylori.

Authors:  Sally A El-Zahaby; Abeer A Kassem; Amal H El-Kamel
Journal:  Saudi Pharm J       Date:  2014-03-06       Impact factor: 4.330

7.  Bio-mimetic drug delivery systems designed to help the senior population reconstruct melatonin plasma profiles similar to those of the healthy younger population.

Authors:  Ying Li; Liuyi Wang; Li Wu; Xueju Zhang; Xue Li; Zhen Guo; Haiyan Li; Peter York; Shuangying Gui; Jiwen Zhang
Journal:  Acta Pharm Sin B       Date:  2014-01-23       Impact factor: 11.413

8.  Formulation and evaluation of fixed-dose combination of bilayer gastroretentive matrix tablet containing atorvastatin as fast-release and atenolol as sustained-release.

Authors:  Sanjay Dey; Sankha Chattopadhyay; Bhaskar Mazumder
Journal:  Biomed Res Int       Date:  2014-01-02       Impact factor: 3.411

9.  Matrix-mini-tablets of lornoxicam for targeting early morning peak symptoms of rheumatoid arthritis.

Authors:  Abdul Hadi Mohd; Nidagurthi Guggilla Raghavendra Rao; Srinivasa Rao Avanapu
Journal:  Iran J Basic Med Sci       Date:  2014-05       Impact factor: 2.699

10.  Formulation and evaluation of ileo-colonic targeted matrix-mini-tablets of Naproxen for chronotherapeutic treatment of rheumatoid arthritis.

Authors:  Mohd Abdul Hadi; N G Raghavendra Rao; A Srinivasa Rao
Journal:  Saudi Pharm J       Date:  2015-03-20       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.